Interactions between human immunodeficiency virus type 1 reverse transcriptase, tRNA primer, and nucleocapsid protein during reverse transcription

Journal of Human Virology

Volumn 3, Issue 1, 2000, Pages 16-26

  Hsu, Mayla ^b   Wainberg, Mark A ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NONE

Author keywords

Human immunodeficiency virus type 1; Nucleocapsid protein; Reverse transcriptase

Indexed keywords

DOUBLE STRANDED DNA; NUCLEOCAPSID PROTEIN; RNA DIRECTED DNA POLYMERASE; TRANSFER RNA;

ARTICLE; BINDING SITE; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

ANTI-HIV AGENTS; AZO COMPOUNDS; BINDING SITES; DNA PRIMERS; DNA, VIRAL; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; LIFE CYCLE STAGES; NUCLEOCAPSID PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033911631     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (108)

1. Baltimore D. RNA-clependent DNA polymerase in virions of RNA tumor viruses. Nature 1970;226:1209-1211.
2. Temin HM, Mizutani S. RNA-directed DNA polymerase in virions of Rous sarcoma virus. Nature 1970;226:1211-1213.
3. Götte M, Li X, Wainberg MA. HIV-1 reverse transcription: a brief overview focused on structure-function relationships among molecules involved in initiation of the reaction. Arch Biochem Biophys 1999;365:199-210.
4. Prasad VR. Genetic analysis of retroviral reverse transcriptase structure and function. In: Skalka AM, Goff SP, eds. Reverse Transcriptase, vol 23. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1993:135-162.
5. DiMarzo Veronese F, Copeland TD, DeVico AL, et al. Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science 1986;231: 1289-1291.
6. LeGrice SFJ, Naas T, Wohlgensinger B, Schatz O. Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase. EMBO J 1991;10:3905-3911.
7. Jacques PS, Wöhrl BM, Howard KJ, LeGrice SFJ. Modulation of HIV-1 reverse transcriptase function in "selectively deleted" p66/p51 heterodimers. J Biol Chem 1994; 269:1388-1393.
8. Kohlstaedt LA, Wang J, Friedman JM, Rice PA, Steitz TA. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 1992; 256:1783-1790.
9. Jacobo-Molina A, Ding J, Nanni RG, et al. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc Natl Acad Sci USA 1993;90:6320-6324.
10. Rodgers DW, Gamblin SJ, Harris BA, et al. The structure of unliganded reverse transcriptase from the human immunodeficiency virus. Proc Natl Acad Sci USA 1995;92: 1222-1226.
11. Huang H, Chopra R, Verdine GL, Harrison SC. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 1998;282:1669-1675.
12. Ghosh M, Williams J, Powell MD, Levin JG, LeGrice SFJ. Mutating a conserved motif of the HIV-1 reverse transcriptase palm subdomain alters primer utilization. Biochemistry 1997;36:5758-5768.
13. Powell MD, Ghosh M, Jacques PS, Howard KJ, LeGrice SFJ, Levin JG. Alanine-scanning mutations in the "primer grip" of p66 HIV-1 reverse transcriptase result in selective loss of RNA priming activity. J Biol Chem 1997;272: 13262-13269.
14. Gopalakrishnan V, Peliska JA, Benkovic SJ. Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNaseH activities. Proc Natl Acad Sci USA 1992;89: 10763-10767.
15. Ratner L, Haseltine W, Patarca R, et al. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 1985; 313:277-283.
16. Mak J, Kleiman L. Primer tRNAs for reverse transcription. J Virol 1997;71:8087-8095.
17. Leis J, Aiyar A, Cobrinik D. Regulation of initiation of reverse transcription of retroviruses. In: Skalka AM, Goff SP, eds. Reverse Transcriptase, vol 23. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1993:33-47.
18. Götte M, Fackler S, Hermann T, et al. HIV-1 reverse transcriptase-associated RNaseH cleaves RNA/RNA in arrested complexes: implications for the mechanism by which RNaseH discriminates between RNA/RNA and RNA/DNA. EMBO J 1995;14:833-841.
19. Panganiban AT, Fiore D. Ordered interstrand and intrastrand DNA transfer during reverse transcription. Science 1988;241:1064-1069.
20. Hu W-S, Temin HM. Retroviral recombination and reverse transcription. Science 1990;250:1227-1233.
21. Charneau P, Clavel F. A single-stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. J Virol 1991;65:2415-2421.
22. Charneau P, Alizon M, Clavel F. A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J Virol 1992;66:2814-2820.
23. Pullen KA, Champoux JJ. Plus-strand origin for human immunodeficiency virus type 1: implications for integration. J Virol 1990;64:6274-6277.
24. Smith JS, Roth MJ. Specificity of human immunodeficiency virus type-associated ribonuclease H in removal of the minus-strand primer tRNA (lys3). J Biol Chem 1992;267:15071-15079.
25. Champoux JJ. Roles of ribonuclease H in reverse transcription. In: Skalka AM, Goff SP, eds. Reverse Transcriptase, vol 23. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1993:103-117.
26. Roth MJ, Schwartzberg PL, Goff SP. Structure of the termini of DNA intermediates in the integration of retroviral DNA: dependence on IN function and terminal DNA sequence. Cell 1989;58:47-54.
27. Isel C, Ehresmann C, Keith G, Ehresmann B, Marquet R. Two step synthesis of (-) strong-stop DNA by avian and murine reverse transcriptases in vitro. Nucleic Acids Res 1997;25:545-552.
28. Isel C, Westhof E, Massire C, et al. Structural basis for the specificity of the initiation of HIV-1 reverse transcription. EMBOJ 1999;18:1038-1048.
29. Lanchy J-M, Ehresmann C, LeGrice SFJ, Ehresmann B, Marquet R. Binding and kinetic properties of HIV-1 reverse transcriptase markedly differ during initiation and elongation of reverse transcription. EMBO J 1996;15: 7178-7187.
30. gag-pol in mediating the selective incorporation of tRNAlys into human immunodeficiency virus type 1 particles. J Virol 1994;68:2065-2072.
31. lys3 modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcription. J Biol Chem 1993;268:25269-25272.
32. Jiang M, Mak J, Ladha A, et al. Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J Virol 1993;67:3246-3253.
33. Barat C, Lullien V, Schatz O, et al. HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA. EMBO J 1989;8:3279-3285.
34. lys3 complexes. J Biol Chem 1993;268:13617-13624.
35. lys3 to reverse transcriptase from human immunodeficiency virus type 1. EMBO J 1995;14.
36. lys3 binding and the consequences for (-)-strand DNA synthesis. J Biol Chem 1998;273:14523-14532.
37. Rhim H, Park J, Morrow CD. Deletions in the tRNAlys primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription. J Virol 1991;65:4555-4564.
38. Li X, Mak J, Arts EJ, et al. Effects of alterations of primer-binding site sequences of human immunodeficiency virus type-1 replication. J Virol 1994;68:6198-6206.
39. ys3 onto a noncomplementary primer binding site within the HIV-1 RNA genome in vitro. Proc Natl Acad Sci USA 1997;94:13530-13535.
40. Wakefield JK, Rhim H, Morrow CD. Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site. J Virol 1994;68:1605-1614.
41. Liang C, Rong L, Gotte M, et al. Mechanistic studies of early pausing events during initiation of HIV-1 reverse transcription. J Biol Chem 1998;273:21309-21315.
42. Liang C, Li X, Rong L, et al. The importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity. J Virol 1997;71:5750-5757.
43. lys3/HIV-1 RNA (primer/ template) complex. Nucleic Acids Res 1998;26:1198-1204.
44. Aiyar A, Cobrinik D, Ge Z, Kung H-J, Leis J. Interaction between retroviral U5 RNA and the TYC loop of the tRNAtrp primer is required for efficient initiation of reverse transcription. J Virol 1992;66:2464-2472.
45. Li X, Liang C, Quan Y, et al. Identification of sequences downstream of the primer binding site that are important for efficient replication of human immunodeficiency virus type 1. J Virol 1997;71:6003-6010.
46. lys3 (template/primer) complex. J Mol Biol 1995;247:236-250.
47. lys3. Nucleic Acids Res 1991;19:751-757.
48. lys3. EMBO J 1996;15:917-924.
49. lys3 as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction. J Biol Chem 1994;269:14672-14680.
50. Huber HE, McCoyJM, Seehra JS, Richardson CC. Human immunodeficiency virus 1 reverse transcriptase. J Biol Chem 1989;264:4669-4678.
51. Majumdar C, Abbotts J, Broder S, Wilson SH. Studies on the mechanism of human immunodeficiency virus reverse transcriptase. J Biol Chem 1988;263:15657-15665.
52. Reardon JE. Human immunodeficiency virus reverse transcriptase: a kinetic analysis of RNA-dependent and DNA-dependent DNA polymerization. J Biol Chem 1993;268:8743-8751.
53. Abbotts J, Bebenek K, Kunkel TA, Wilson SH. Mechanism of HIV-1 reverse transcriptase. J Biol Chem 1993; 268:10312-10323.
54. Klarmann GJ, Schauber CA, Preston BD. Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequences in vitro. J Biol Chem 1993;268:9793-9802.
55. Hsieh J-C, Zinnen S, Modrich P. Kinetic mechanism of the DNA-dependent DNA polymerase activity of human immunodeficiency virus reverse transcriptase. J Biol Chem 1993;268:24607-24613.
56. Peliska JA, Benkovic SJ. Mechanism of DNA strand transfer reactions catalyzed by HIV-I reverse transcriptase. Science 1992;258:1112-1118.
57. Cirino NM, Cameron CE, Smith JS, et al. Divalent cation modulation of the ribonuclease functions of human immunodeficiency virus reverse transcriptase. Biochemistry 1995;34:9936-9943.
58. Hostomsky Z, Hostomska Z, Hudson GO, Moomaw EW, Nodes BR. Reconstitution in vitro of RNaseH activity by using purified N-terminal and C-terminal domains of human immunodeficiency virus type 1 reverse transcriptase. Proc Natl Acad Sci USA 1991;88:1148-1152.
59. Hostomsky Z, Hughes SH, Goff SP, LeGrice SFJ. Redesignation of the RNaseD activity associated with retroviral reverse transcriptase as RNaseH*. J Virol 1994;68:1970-1971.
60. Götte M, Maier G, Onori AM, Cellai L, Wainberg MA, Heumann H. Temporal coordination between initiation of HIV (+)strand DNA synthesis and primer removal. J Biol Chem 1999;274:11159-11169.
61. Di Marzo Veronese F, Rahman R, Copeland TD, Oroszlan S, Gallo RC, Samgadharan MG. Immunological and chemical analysis of p6, the carboxyl-terminal fragment of HIV p15. AIDS Res Hum Retroviruses 1987;3:253-264.
62. South TL, Blake PR, Sowder RCI, Arthur LO, Henderson LE, Summers MF. The nucleocapsid protein isolated from HIV-1 particles binds zinc and forms retroviral-type zinc fingers. Biochemistry 1990;29:7786-7789.
63. Henderson LE, Bowers MA, Sowder RCI, et al. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences. J Virol 1992;66:1856-1865.
64. Sheng N, Erickson-Viitanen S. Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease is RNA dependent. J Virol 1994;68:6207-6214.
65. Darlix J-L, Lapadat-Topolsky M, de Rocquigny H, Roques BP. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J Mol Biol 1995;254:523-537.
66. Morellet N, de Rocquigny H, Mély Y, et al. Conformational behaviour of the active and inactive forms of the nucleocapsid NCp7 of HIV-1 studied by 1H NMR. J Mol Biol 1994;235:287-301.
67. Lys3 in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site. J Virol 1996;70:4996-5004.
68. Rong L, Liang C, Hsu M, et al. Roles of the human immunodeficiency virus type 1 nucleocapsid protein in annealing and initiation versus elongation in reverse transcription of viral negative-strand strong-stop DNA. J Virol 1998;72:9353-9358.
69. Prats AC, Sarih L, Gabus C, Litvak S, Keith G, Darlix JL. Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA. EMBO J 1988; 7:1777-1783.
70. Khan R, Giedroc DP. Recombinant human immunodeficiency virus type 1 nucleocapsid (NCp7) protein unwinds tRNA. J Biol Chem 1992;267:6689-6695.
71. lys3 to human immunodeficiency virus type 1 primer binding site is critically dependent on the NCp7 zinc fingers structure. J Biol Chem 1998;273:4819-4822.
72. Feng Y-X, Campbell S, Harvin D, Ehresmann B, Ehresmann C, Rein A. The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site. J Virol 1999;73:4251-4256.
73. gag-pol and tRNALys incorporation into human immunodeficiency virus type 1. J Virol 1997;71:4378-4384.
74. Druillennec S, Caneparo A, de Rocquigny H, Roques BP. Evidence of interactions between the nucleocapsid protein NCp7 and the reverse transcriptase of HIV-1. J Biol Chem 1999;274:11283-11288.
75. Lener D, Tanchou V, Roques BP, LeGrice SFJ, Darlix J-L. Involvement of HIV-1 nucleocapsid protein in the recruitment of reverse transcriptase into nucleoprotein complexes formed in vitro. J Biol Chem 1998;273: 33781-33786.
76. Wu W, Henderson LE, Copeland TD, et al. Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. J Virol 1996;70:7132-7142.
77. Ji X, Klarmann GJ, Preston BD. Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro. Biochemistry 1996;35:132-143.
78. DeStefano JJ. Interaction of human immunodeficiency virus nucleocapsid protein with a structure mimicking a replication intermediate. J Biol Chem 1996;271:16350-16356.
79. Allain B, Lapadat-Topolsky M, Berlioz C, Darlix J-L. Transactivation of the minus-strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome. EMBO J 1994;13:973-981.
80. Tsuchihashi Z, Brown PO. DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein. J Virol 1994;68:5863-5870.
81. You JC, McHenry CS. Human immunodeficiency virus nucleocapsid protein accelerates strand transfer of the terminally redundant sequences involved in reverse transcription. J Biol Chem 1994;269:31491-31495.
82. Guo J, Henderson LE, Bess J, Kane B, Levin JG. Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA. J Virol 1997;71: 5178-5188.
83. Rodríguez-Rodríguez L, Tsuchihashi Z, Fuentes GM, Bambara RA, Fay PJ. Influence of human immunodeficiency virus nucleocapsid protein on synthesis and strand transfer by the reverse transcriptase in vitro. J Biol Chem 1995;270:15005-15011.
84. Peliska JA, Balasubramanian S, Giedroc DP, Benkovic SJ. Recombinant HIV-1 nucleocapsid protein accelerates HIV-1 reverse transcriptase catalyzed DNA strand transfer reactions and modulates RNaseH activity. Biochemistry 1994;33:13817-13823.
85. Cameron CE, Ghosh M, LeGrice SFJ, Benkovic S. Mutations in HIV reverse transcriptase which alter RNaseH activity and decrease strand transfer efficiency are suppressed by HIV nucleocapsid protein. Proc Natl Acad Sci USA 1997;94:6700-6705.
86. Negroni M, Buc H. Recombination during reverse transcription: an evaluation of the role of the nucleocapsid protein. J Mol Biol 1999;286:15-31.
87. Berkowitz RD, Ohagen A, Hoglund S, Goff SP. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo. J Virol 1995;69: 6445-6456.
88. Tanchou V, Gabus C, Rogemond V, Darlix J-L. Formation of stable and functional HIV-1 nucleoprotein complexes in vitro. J Mol Biol 1995;252:563-571.
89. Feng Y-X, Copeland TD, Henderson LE, et al. HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro. Proc Natl Acad Sci USA 1996;93: 7577-7581.
90. Berglund JA, Charpentier B, Rosbash M. A high affinity binding site for the HIV-1 nucleocapsid protein. Nucleic Acids Res 1997;25:1042-1049.
91. De Guzman RN, Wu ZR, Stalling CC, Pappalardo L, Borer PN, Summers MF. Structure of the HIV-1 nucleocapsid protein bound to the SL3 Psi-RNA recognition element. Science 1998;279:384-388.
92. Schmalzbauer E, Strack B, Dannull J, Guehmann S, Moelling K. Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro. J Virol 1996;70:771-777.
93. de Rocquigny H, Gabus C, Vincent A, Fournié-Zaluski M-C, Roques B, Darlix J-L. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc Natl Acad Sci USA 1992;90:6472-6476.
94. Lapadat-Topolsky M, Pernelle C, Borie C, Darlix J-L. Analysis of the nucleic acid annealing activities of nucleocapsid protein from HIV-1. Nucleic Acids Res 1995;23:2434-2441.
95. Gorelick RJ, Chabot DJ, Rein A, Henderson LE, Arthur LO. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J Virol 1993;67:4027-4036.
96. Dorfman T, Luban J, Goff SP, Haseltine WA, Göttlinger HG. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J Virol 1993;67:6159-6169.
97. Gorelick RJ, Gagliardi TD, Bosche WJ, et al. Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences. Virology 1999;256:92-104.
98. Urbaneja MA, Kane BP, Johnson DG, Gorelick RJ, Henderson LE, Casas-Finet JR. Binding properties of the human immunodeficiency virus type 1 nucleocapsid protein p7 to a model RNA: elucidation of the structural determinants for function. J Mol Biol 1999;287:59-75.
99. Tanchou V, Decimo D, Pechoux C, et al. Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication. J Virol 1998;72:4442-4447.
100. Gorelick RJ, Nigida SMJ, Bess JWJ, Arthur LO, Henderson LE, Rein A. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J Virol 1990;64:3207-3211.
101. Rein A, Harvin DP, Mirro J, Ernst SM, Gorelick RJ. Evidence that a central domain of nucleocapsid protein is required for RNA packaging in murine leukemia virus. J Virol 1994;68:6124-6129.
102. Ottmann M, Gabus C, Darlix J-L. The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity. J Virol 1995;69:1778-1784.
103. Berthoux L, Péchoux C, Ottmann M, Morel G, Darlix J-L. Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis. J Virol 1997;71:6973-6981.
104. Poon DTK, WuJ, Aldovini A. Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity. J Virol 1996;70:6607-6616.
105. Rice WG, Turpin JA, Huang M, et al. Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein. Nat Med 1997;3:341-345.
106. Rice WG, Supko JG, Malspeis L, et al. Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science 1995;270:1194-1197.
107. Tummino PJ, Scholten JD, Harvey PJ, et al. The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti-HIV activity. Proc Natl Acad Sci USA 1996;93:969-973.
108. Tummino PJ, Harvey PJ, McQuade T, et al. The human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: correlation with anti-HIV and virucidal activities. Antimicrob Agents Chemother 1997; 41:394-400.